Skip to product content

ACTIVE PHARMACEUTICAL INGREDIENT

Ibuprofen API

Research Ibuprofen API through FDA DMF and China CDE records. Compare reported companies, review filing statuses and confirm the free-acid identity before preparing your sourcing shortlist.

Complete data requires an active subscription. Already subscribed? Sign in to access your data.

This Ibuprofen profile covers the ordinary free acid, CAS 15687-27-1. Dexibuprofen, other single-enantiomer material, sodium, lysine and arginine salts, finished dosage forms and processed mixtures are excluded. Selection follows reported names and subjects; the registries do not independently verify the CAS or batch composition of every entry.

Ibuprofen registration data overview

Ibuprofen registry coverage: 33 FDA API-related DMF entries and 14 CDE API registrations selected by substance name. Browse the free samples, then use a subscription to search, filter and export the complete available Ibuprofen records.

0 documented company-name correspondences

The registries have different snapshot dates and status definitions. Counts describe records, not qualified suppliers. Company fields retain their original wording, including repeated parties. No cross-registry company-name correspondences are documented for this profile.

Personal API data subscription

$19.00 per month

$149.00 per year

Billed $149.00 every year

This profile: 33 FDA DMF records, 14 CDE registrations and 0 company-name correspondences.

Subscription benefits and CSV samples
  • Complete available registry records
  • Search and status filters
  • Documented company-name correspondences
  • CSV exports with sources

One personal account can access subscription datasets currently available on APIRFQ. Coverage varies by product. This does not include quotations, supplier qualification or live monitoring.

Reported companies in Ibuprofen registry records

Use the Ibuprofen registry tables below to inspect original holder and company fields. No cross-registry company-name correspondences are documented. Similar names, translations or membership of the same group do not verify an identical legal entity or manufacturing site.

Free previewShowing 0 sample records of 0.

0 company-name correspondences

No exact company-name correspondences are documented for these snapshots.

Other records remain available below and in the registry tables. A missing name correspondence does not imply a missing registration.

Original reported names are preserved. A CDE company field may contain several named parties; their roles are not inferred from name order. Unmatched names are not treated as ineligible suppliers.

US REGULATORY RECORDS

Ibuprofen FDA Drug Master Files

Inspect Ibuprofen DMF holders, original subjects, submission dates and activity status. Included subjects identify the API or its manufacture; a Type II filing alone does not establish supplier qualification or current material availability.

API DMF records: 33. Distinct reported holder names: 33.

9Active (A)

24Inactive (I)

A = active; I = inactive. DMFs are neither approved nor disapproved by FDA. These entries do not establish supplier qualification, manufacturing-site approval, dossier access or current availability.

Free previewShowing 3 sample records of 33.

  • KNOLL PHARMA CHEMICALSDMF number 2078Inactive (I)Record details
    DMF number
    2078
    Activity status
    Inactive (I)
    DMF type
    II
    Initial submission
    1973-03-02
    Reported holder
    KNOLL PHARMA CHEMICALS
    Reported subject
    IBUPROFEN
  • ETHYL CORPDMF number 2907Inactive (I)Record details
    DMF number
    2907
    Activity status
    Inactive (I)
    DMF type
    II
    Initial submission
    1977-04-28
    Reported holder
    ETHYL CORP
    Reported subject
    IBUPROFEN
  • ACIC LTDDMF number 4329Inactive (I)Record details
    DMF number
    4329
    Activity status
    Inactive (I)
    DMF type
    II
    Initial submission
    1981-10-19
    Reported holder
    ACIC LTD
    Reported subject
    PROCEDURES FOR THE MANUF OF IBUPROFEN

Free preview

More records available with a subscription: 30.

Inclusion criteria
  • Selected Ibuprofen API-related Type II records: 33. Includes ordinary free-acid subjects, pharmacopoeial name variants and DMF 4329, which describes procedures for manufacture. Subject selection does not independently verify CAS 15687-27-1 for each filing.
  • Excludes isolated enantiomers, sodium, lysine and arginine salts, tablets, capsules, softgels, coated or diluted preparations and direct-compression granules. DMF 2720 concerns facility controls rather than an identified API product; 9661 describes plasma analysis. DCI-63, DC100 and branded preparations are excluded from this unformulated API selection, without inferring their exact composition.
  • All six original fields are preserved, including subject whitespace. Only Excel submission dates are converted to ISO format. FDA activity statuses describe the June 30, 2026 snapshot; they are not current supplier assessments.

CHINA REGULATORY RECORDS

Ibuprofen NMPA CDE registrations

Inspect the Ibuprofen registration numbers, original Chinese company fields and reported review status. Expand each Ibuprofen entry to see all source columns, including unfilled cells, packaging and approval references.

14 name-selected API registration records

12Approved or qualifying prior approval (A)

2Technical review not passed or unlinked (I)

CDE A and I describe Chinese review status independently of FDA activity. A can follow joint review, transfer of qualifying prior approvals or independent API review. I means technical review has not been passed or the material has not been linked to a formulation registration. Reported validity dates and status do not independently establish current supplier qualification.

Free previewShowing 3 sample records of 14.

  • 山东新华制药股份有限公司Registration number Y20180001074Approved or qualifying prior approval (A)Record details
    Registration number
    Y20180001074
    Reported substance name
    布洛芬
    Reported company names
    山东新华制药股份有限公司
    Reported company addresses
    山东省淄博市高新技术产业开发区东部化工区
    Reported product origin
    Domestic (国产)
    Reported packaging
    每件净重25kg、15kg
    Reported specification
    无
    Record updated
    2024-09-04
    Joint review status
    Approved or qualifying prior approval (A)
    Reported validity date
    2029-08-27
    Source remarks
    Not provided by source
  • 淄博新华-百利高制药有限责任公司Registration number Y20190002336Approved or qualifying prior approval (A)Record details
    Registration number
    Y20190002336
    Reported substance name
    布洛芬
    Reported company names
    淄博新华-百利高制药有限责任公司
    Reported company addresses
    山东省淄博市高新技术产业开发区化工区
    Reported product origin
    Domestic (国产)
    Reported packaging
    Not provided by source
    Reported specification
    Not provided by source
    Record updated
    2024-07-27
    Joint review status
    Approved or qualifying prior approval (A)
    Reported validity date
    2029-07-15
    Source remarks
    国药准字H20056884
  • 华中药业股份有限公司Registration number Y20190003113Approved or qualifying prior approval (A)Record details
    Registration number
    Y20190003113
    Reported substance name
    布洛芬
    Reported company names
    华中药业股份有限公司
    Reported company addresses
    湖北省襄阳市岘山路118号
    Reported product origin
    Domestic (国产)
    Reported packaging
    20kg/桶
    Reported specification
    Not provided by source
    Record updated
    2025-06-11
    Joint review status
    Approved or qualifying prior approval (A)
    Reported validity date
    2030-06-16
    Source remarks
    国药准字H42021367

Free preview

More records available with a subscription: 11.

Inclusion criteria
  • Includes 14 registrations named exactly 布洛芬, associated with this Ibuprofen free-acid reference profile. The supplied CSV has no CAS column; it does not independently establish CAS 15687-27-1 for individual registrations.
  • Excludes 精氨酸布洛芬 (arginine salt), 右布洛芬 and 右旋布洛芬 (single-enantiomer material). The substring match 扎托布洛芬 is zaltoprofen, a different substance, and is also excluded.
  • All eleven columns and the source row order are preserved. Blank fields remain blank and display as Not provided by source. Repeated company names and multiple addresses are retained; no party roles or current validity are inferred. The October 5, 2026 export is a dated snapshot.

Ibuprofen chemical identity

Ibuprofen is a monocarboxylic acid with a 4-isobutylphenyl group on a propionic-acid backbone. This profile uses CAS 15687-27-1 for the ordinary free acid. Dexibuprofen identifies the S enantiomer and is excluded. Sodium, lysine and arginine salts are separate chemical forms. Reference identifiers define this page; a registry name alone does not confirm the chemical composition of a filing.

Ibuprofen — 2D chemical structure

Loading molecular structure…

Open structure in ChEBI
CAS number
15687-27-1
KEGG Drug: Ibuprofen

Reference identity; CAS is not independently confirmed for each registry entry.

ChEBI identifier
CHEBI:5855
ChEBI: Ibuprofen identity and structure
KEGG Drug identifier
D00126
KEGG Drug: Ibuprofen
InChIKey
HEFNNWSXXWATRW-UHFFFAOYSA-N
ChEBI: Ibuprofen identity and structure

Ibuprofen chemical properties

Ibuprofen reference properties describe the neutral free acid. A shared formula does not distinguish isolated enantiomers. Confirm chemical form, assay basis, impurity limits and particle-size requirements against the proposed material specification and analytical documentation.

Molecular weight
206.285 g/mol
ChEBI: Ibuprofen identity and structure

Ibuprofen identity and regulatory resources

Check the Ibuprofen reference structure, distinguish the isolated enantiomer and review the meaning of registry records.

Ibuprofen API sourcing questions

What chemical form does this Ibuprofen API page cover?

Ibuprofen here means the ordinary free acid, CAS 15687-27-1, rather than an isolated enantiomer or salt. ChEBI reports formula C13H18O2, molecular weight 206.285 g/mol and exact mass 206.13068 Da. KEGG cross-checks the name and CAS. These are reference identifiers, not independently verified CAS assignments for every filing.

Is dexibuprofen the same as ordinary Ibuprofen?

Dexibuprofen is the S enantiomer. This Ibuprofen selection excludes subjects naming dexibuprofen, S-ibuprofen or S-(+)-ibuprofen and CDE entries named 右布洛芬 or 右旋布洛芬. Molecular formula alone cannot distinguish these materials. Confirm stereochemical identity in the proposed specification before treating two materials as equivalent.

Are Ibuprofen salts, tablets and direct-compression grades included?

No. Sodium, lysine and arginine salts, finished tablets and capsules, coated or diluted preparations and direct-compression granules are outside this Ibuprofen free-acid selection. A salt or prepared mixture should be assessed against its own chemical identity and composition rather than counted as another record for the same API.

Which FDA Ibuprofen records are included?

The selection includes ordinary Ibuprofen subjects, pharmacopoeial name variants and the manufacturing-procedure filing DMF 4329. It excludes facility-control filing 2720, plasma-analysis filing 9661 and subjects identifying other chemical forms or preparations. Type II includes more than drug substances, so the subject is checked alongside the type.

Does an active Ibuprofen DMF mean FDA approval?

No. FDA A means active and I means inactive. FDA states that DMFs are neither approved nor disapproved. An active Ibuprofen entry does not establish an approved supplier, a qualified manufacturing site, access to the dossier or current stock. Verify the current filing and the documentation needed for your application.

How are the China CDE Ibuprofen records selected?

CDE inclusion requires the exact name 布洛芬. Original company names, addresses, packaging, dates, review codes and approval references are preserved across all eleven fields. The CSV has no CAS column, so selection does not independently confirm chemical identity. Repeated parties within one company field do not establish extra suppliers.

What do the Ibuprofen CDE A and I codes mean?

CDE A can reflect joint technical review, transfer of qualifying prior approvals or independent API review. I covers technical review not passed or a registration not yet linked to a formulation. These are separate from FDA activity codes. Read the Ibuprofen record in its Chinese regulatory context and verify its current status.

Are these Ibuprofen records current supplier qualifications?

No. FDA records use the June 30, 2026 list cutoff; CDE records use the October 5, 2026 export. Neither snapshot establishes current supply, batch quality or site qualification. For an Ibuprofen sourcing review, obtain the proposed specification, certificate of analysis, manufacturing-site details and applicable dossier authorization directly from the relevant company.

Why are Ibuprofen companies not matched across the registries?

No verified cross-registry company-name correspondences are documented for this Ibuprofen profile. Original holder and company fields remain available for comparison. Similar names, translated names or a shared corporate group do not establish that the same legal entity or manufacturing site is involved.

What Ibuprofen data can I access before subscribing?

The free Ibuprofen preview contains sample rows from each available registry, with CSV samples of those rows. A subscription opens the complete available dataset for search, status filtering and CSV export. Coverage refers to these dated source selections; it does not include quotations, supplier qualification or live registry monitoring.

ChEBI: Ibuprofen identity and structureKEGG Drug: IbuprofenChEBI: DexibuprofenFDA DMF list: Q2 2026 snapshotNMPA CDE API registry snapshotFDA: Types of Drug Master FilesFDA: Drug Master FilesChina API registration status explained

Data sources

Primary references for chemical identity, registration records and status definitions. Open each source to check its scope and current information.

ChEBI: Ibuprofen identity and structure

Open source reference

EMBL-EBI

Provides the free-acid formula, reference masses, InChIKey and SMILES structure.

View citation evidence

“2-[4-(2-methylpropyl)phenyl]propanoic acid”

EMBL-EBI

IUPAC name in ChEBI CHEBI:5855; properties and structure come from the same entry.

KEGG Drug: Ibuprofen

Open source reference

KEGG

Cross-checks the Ibuprofen name and CAS 15687-27-1.

View citation evidence

“Ibuprofen (JP19/USP/INN)”

KEGG

Name field in KEGG Drug D00126; CAS is reported in the same entry.

ChEBI: Dexibuprofen

Open source reference

EMBL-EBI

Identifies dexibuprofen as the separate S-enantiomer entry used to distinguish excluded single-enantiomer filings.

View citation evidence

“dexibuprofen”

EMBL-EBI

ChEBI name in CHEBI:43415; the stereochemical structure identifies the S enantiomer.

FDA DMF list: Q2 2026 snapshot

Open source reference

U.S. Food and Drug Administration

Displayed records come from the supplied Q2 workbook with a June 30, 2026 cutoff. The official page now offers a later quarterly list.

View citation evidence

“PROCEDURES FOR THE MANUF OF IBUPROFEN”

U.S. Food and Drug Administration

Exact subject of DMF 4329 in worksheet 2Q2026-EXCEL of the supplied workbook.

FDA: Drug Master Files

Open source reference

U.S. Food and Drug Administration

Explains DMF use and review. A listing or active status does not establish approval of a supplier or product.

View citation evidence

“Are neither approved nor disapproved.”

U.S. Food and Drug Administration

FDA statement about DMFs; their technical contents are reviewed with applications that reference them.

FDA: Types of Drug Master Files

Open source reference

U.S. Food and Drug Administration

Type II is broader than APIs, so the reported subject must also be checked.

View citation evidence

“Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation; or Drug Product”

U.S. Food and Drug Administration

FDA Type II category heading.

NMPA CDE API registry snapshot

Open source reference

Center for Drug Evaluation, National Medical Products Administration

The October 5, 2026 export supplies the name-selected Ibuprofen registrations, original company fields, status codes and empty cells.

View citation evidence

“布洛芬”

Center for Drug Evaluation, National Medical Products Administration

Exact reported substance name for the included registrations in the supplied CSV, including Y20260000554.

China API registration status explained

Open source reference

Liaoning Medical Products Administration

Official explanation of A and I, including joint review, qualifying prior approvals and independent API review.

View citation evidence

“未通过技术审评或尚未与制剂注册进行关联的标识为“I”。”

Liaoning Medical Products Administration

Regulator explanation published February 18, 2025: I covers technical review not passed or a registration not yet linked to a formulation.

Continue your Ibuprofen API research

Compare Ibuprofen registry names, statuses and chemical-form boundaries using the free samples. Subscribe to search, filter and export the complete available FDA and CDE records for your sourcing review.

Complete data requires an active subscription. Already subscribed? Sign in to access your data.

Report a data issue

Report an Ibuprofen data issue with the page address, registry number and supporting official evidence. APIRFQ support handles data corrections. Contact the relevant company separately about material specifications, dossier access or supply.

Contact data support